PEG vs SPRO · P/E 18, rev $10.29B vs P/E 9.6, rev $48.0M
Public Service Enterprise Group Inc (PEG) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
PEG currently screens at market cap $39.57B and trailing P/E 17.6. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the PEG and SPRO stock pages for the full models.
Not investment advice.